11/22
07:56 am
bolt
Bolt Biotherapeutics (NASDAQ:BOLT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Bolt Biotherapeutics (NASDAQ:BOLT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/12
04:53 pm
bolt
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/12
04:05 pm
bolt
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Low
Report
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
10/24
05:32 am
bolt
Bolt Biotherapeutics (NASDAQ:BOLT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Neutral
Report
Bolt Biotherapeutics (NASDAQ:BOLT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
10/21
07:27 am
bolt
Bolt Biotherapeutics (NASDAQ:BOLT) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Low
Report
Bolt Biotherapeutics (NASDAQ:BOLT) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
10/20
07:20 am
bolt
Bolt Biotherapeutics (NASDAQ:BOLT) was given a new $7.00 price target on by analysts at HC Wainwright.
Low
Report
Bolt Biotherapeutics (NASDAQ:BOLT) was given a new $7.00 price target on by analysts at HC Wainwright.
10/2
05:45 am
bolt
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 [Yahoo! Finance]
Low
Report
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 [Yahoo! Finance]
10/1
04:05 pm
bolt
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
High
Report
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027